Microsimulation model to predict incremental value of biomarkers added to prognostic models

Journal of the American Medical Informatics Association : JAMIA
Karol M PencinaMichael J Pencina

Abstract

It is unclear to what extent simulated versions of real data can be used to assess potential value of new biomarkers added to prognostic risk models. Using data on 4522 women and 3969 men who contributed information to the Framingham CVD risk prediction tool, we develop a simulation model that allows assessment of the added contribution of new biomarkers. The simulated model matches closely the one obtained using real data: discrimination area under the curve (AUC) on simulated vs actual data is 0.800 vs 0.799 in women and 0.778 vs 0.776 in men. Positive correlation with standard risk factors decreases the impact of new biomarkers (ΔAUC 0.002-0.024), but negative correlation leads to stronger effects (ΔAUC 0.026-0.101) than no correlation (ΔAUC 0.003-0.051). We suggest that researchers construct simulation models similar to the one proposed here before embarking on larger, expensive biomarker studies based on actual data.

References

Feb 15, 2007·JAMA : the Journal of the American Medical Association·Paul M RidkerNancy R Cook
Sep 21, 2007·Atherosclerosis·Ian GrahamUNKNOWN ESC Committee for Practice Guidelines
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Apr 15, 2009·Circulation·Mark A HlatkyUNKNOWN American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Cou
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Peter W F WilsonChristopher J O'Donnell
Aug 10, 2012·American Journal of Epidemiology·Michael J PencinaPhilip Greenland
Oct 5, 2012·The New England Journal of Medicine·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Jan 26, 2013·Statistics in Medicine·Aasthaa Bansal, Margaret Sullivan Pepe
May 4, 2013·Statistics in Medicine·Olga V DemlerRalph B D'Agostino
Jan 25, 2014·The Journal of Physical Chemistry. a·Wenhui Feng, John F Hershberger
Mar 22, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Marcia R HallGordon J Rustin
Jun 22, 2016·JAMA : the Journal of the American Medical Association·Peter GanzStephen A Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.